Genomics

Unvaccinated Pregnant Women Face Population Health Impacts

by Erin McNemar, MPA

According to UT Southwestern Medical Center researchers, unvaccinated pregnant women are increasingly hospitalized due to COVID-19, impacting population health. The study, which analyzed more than...

Genetic Mutations Key to Precision Medicine, Cancer Prevention

by Erin McNemar, MPA

A recent study indicated that genetic mutations in blood cells caused by smoking and aging-related changed could be risk factors for a rare type of blood cancer that impacts immune cells. The findings...

Using Artificial Intelligence to Detect Anti-cancer Immunity

by Erin McNemar, MPA

UT Southwestern Medical Center and the University of Texas MD Anderson Cancer Center researchers developed an artificial intelligence method to determine anti-cancer immunity. According to...

Deep Learning Model Could Predict Outcomes for HCC Patients

by Erin McNemar, MPA

Cleveland Clinic researchers collaborated with Owkin to develop and validate a deep learning model to predict survival and outcomes for hepatocellular carcinoma (HCC) patients after liver...

Blood Enzyme Activity Predicts Chronic Disease Progression

by Erin McNemar, MPA

SWOG Cancer Research Network researchers have discovered that blood enzyme activity levels could determine the chronic disease progression of breast cancer.  The study indicated that patients...

Neurodegenerative Disease Insights Can Advance Precision Medicine

by Erin McNemar, MPA

Rutgers researchers discovered some of the first molecular insights into how toxic proteins are regulated in neurodegenerative disease, potentially advancing precision medicine efforts. The most...

How Proteins in Acute Myeloid Leukemia Support Precision Medicine

by Erin McNemar, MPA

Sanford Burnham Prebys Medical Discovery Institute scientists discovered that the protein RNF5 plays an unusual role in acute myeloid leukemia (AML). By targeting the specific protein, researchers...

Why Genetic Testing Is Key to Advancing Precision Medicine

by Erin McNemar, MPA

Due to genetics, not every patient responds the same to medications. With genetic testing, providers can better determine the best treatment options for individuals, advancing precision...

Using Predictive, Data Analytics to Expand Knowledge of Alzheimer’s

by Erin McNemar, MPA

Using predictive and data analytics, Brigham and Women’s Hospital researchers developed a resource to better understand the cognitive decline in individuals due to Alzheimer’s disease...

Machine Learning Tool Detects Genetic Syndromes in Children

by Erin McNemar, MPA

Children’s National Hospital researchers developed a machine learning tool that offers rapid genetic screening, potentially accelerating the diagnosis of genetic syndromes in children. The deep...

Determining Family Impact of Genome Sequencing on Newborns

by Erin McNemar, MPA

Genome sequencing can reveal an individual’s risk for specific health conditions throughout their life. While some advocate for testing on all newborns to address disease risks early in life,...

HMS, Clalit Collaboration Seeks to Improve Precision Medicine

by Erin McNemar, MPA

Harvard Medical School (HMS) and Clalit Research Institute are launching a collaborative effort to advance precision medicine. The opportunity for collaborations was enabled by a donation from the...

Developing Precision Medicine for Chronic Kidney Disease

by Erin McNemar, MPA

In a genome-wide association study, Perelman School of Medicine at the University of Pennsylvania researchers identified 182 genes potentially linked to kidney function and 88 genes for hypertension....

Machine Learning Algorithm Predicts Schizophrenia Risk

by Erin McNemar, MPA

By examining specific regions of the human genome, Baylor College of Medicine researchers developed a machine learning algorithm called SPLS-DA to look for epigenetic markers for schizophrenia. The...

Predictive, Data Analytics Used in Genomic Tests for Prostate Cancer

by Erin McNemar, MPA

Using predictive and data analytics, University of Michigan researchers conducted a study that discovered a commercially available genomic test, Decipher Biopsy, could assist in identifying prostate...

DNA Tags, Blood Tests Advance Cancer Care, Precision Medicine 

by Erin McNemar, MPA

Georgetown Lombardi Comprehensive Cancer Center researchers are studying DNA tags in blood-based tests to better assess and treat cancer and other diseases using precision medicine. During cell death,...

Genomic Sequencing Creates Precision Medicine for Cancer Patients

by Erin McNemar, MPA

Researchers at St. Jude Children’s Research Hospital have discovered that comprehensive genomic sequencing of all pediatric cancer patients is achievable and essential in the development of...

Addressing Health Disparities by Improving Genomic Research

by Erin McNemar, MPA

According to the American Heart Association, genomic studies have made significant advancements in chronic heart disease prevention. However, these improvements have not been seen equality across all...

Gene Therapy Improves Neurological Disease, Population Health Management

by Erin McNemar, MPA

A study led by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine shows that a new method of gene therapy is providing...

Genomic Analysis Finds Genetic Factors Linked to Severe COVID-19

by Erin McNemar, MPA

Through genomic analysis, researchers have discovered 13 loci, or locations in the human genome, that are strongly associated with infection or severe COVID-19. The team of researchers has also...